Milziade De Santis
About Milziade De Santis
Milziade De Santis is a Product Specialist in Immuno-Oncology at Bristol Myers Squibb with extensive experience in oncology and clinical research.
Current Role at Bristol Myers Squibb
Milziade De Santis is a Product Specialist in Immuno-Oncology at Bristol Myers Squibb. He has been working in this capacity for over seven years, contributing to advancements in the field of immuno-oncology through his role at the company. His focus includes the development and management of immuno-oncology products, leveraging his extensive knowledge to support the company's initiatives.
Previous Experience at Eisai
Before joining Bristol Myers Squibb, Milziade De Santis worked at Eisai as an Oncology Product Specialist from 2015 to 2016. Prior to this, he was a Medical Science Liaison in oncology at the same company from 2014 to 2015. During his tenure at Eisai, Milziade transitioned from a liaison role to a product specialist within a year, showcasing his adaptability and expertise in the oncology domain.
Clinical Research Background at IQVIA
Milziade De Santis acquired valuable clinical research experience while working at IQVIA. He served as a Clinical Research Associate from 2013 to 2014, where he was involved in various clinical projects. Additionally, he also worked as a Medical Representative at IQVIA from 2011 to 2013, providing support and promoting medical products to healthcare professionals.
Early Career as a Pharmacist and Medical Representative
Milziade De Santis began his career as a pharmacist at Farmacia Comunale Agroverde Aprilia from 2005 to 2006. Following this role, he transitioned to working as a Medical Representative for Servier from 2006 to 2011. During his five years at Servier, Milziade supported the promotion of medical products and gained substantial experience in the pharmaceutical industry.
Educational Background in Pharmacy
Milziade De Santis holds a Doctor of Pharmacy degree from Università degli Studi di Salerno. His educational background in pharmacy provided a solid foundation for his extensive career in the medical and pharmaceutical fields, especially in oncology and immuno-oncology.